Volume 22 (2023)
Volume 21 (2022)
Volume 20 (2021)
Volume 19 (2020)
Volume 18 (2019)
Volume 17 (2018)
Volume 16 (2017)
Volume 15 (2016)
Volume 14 (2015)
Volume 13 (2014)
Volume 12 (2013)
Volume 11 (2012)
Volume 10 (2011)
Low-dose versus standard-dose alteplase for intravenous thrombolysis in patients with acute ischemic stroke in Iran: Results from the safe implementation of treatments in stroke registry

Elyar Sadeghi-Hokmabadi; Abdoreza Ghoreishi; Reza Rikhtegar; Payam Sariaslani; Shahram Rafie; Alireza Vakilian; Ehsan Sharifipour; Masoud Mehrpour; Mohammad Saadatnia; Mohammad Mirza-Aghazadeh-Attari; Mehdi Farhoudi

Volume 20, Issue 4 , October 2021, , Pages 208-213


  Background: Rates of intracranial hemorrhage (ICH) after intravenous thrombolysis (IVT) differ depending on ethnicity, one reason that few Eastern countries have approved a lower dose of alteplase. Data in this regard are scarce in the Middle Eastern region. Methods: The present retrospective study ...  Read More

Evaluation of rivaroxaban versus warfarin for the treatment of cerebral vein thrombosis: A case-control blinded study

Fariborz Khorvash; Mohammad Javad Farajpour-Khanaposhtani; Helia Hemasian; Mohammad Saadatnia

Volume 20, Issue 3 , July 2021, , Pages 125-130


  Background: Anticoagulation therapy following cerebral vein thrombosis (CVT) can improve mortality and morbidity. Vitamin K antagonists are currently the routine oral anticoagulant used for CVT; while by introduction of rivaroxaban, a direct factor Xa inhibitor, the attentions have been deviated toward ...  Read More

Ten-year trend in stroke incidence and its subtypes in Isfahan, Iran during 2003-2013

Ahmad Bahonar; Alireza Khosravi; Fariborz Khorvash; Mohammadreza Maracy; Shahram Oveisgharan; Noushin Mohammadifard; Mohammad Saadatnia; Fatemeh Nouri; Nizal Sarrafzadegan

Volume 16, Issue 4 , October 2017, , Pages 201-209

  Background: As there was no evidence of long-term studies on stroke trend, stroke subtypes and its relationships to stroke risk factors and demographic characteristics in Iran, we aimed to evaluate 10-year trend of stroke incidence and stroke subtypes in Isfahan, Iran.Methods: In a hospital-based retrospective ...  Read More

Modified Atkins diet in adult with refractory epilepsy: A controlled randomized clinical trial

Mohammad Zare; Ali Asghar Okhovat; Ahmad Esmaillzadeh; Jafar Mehvari; Mohammad Reza Najafi; Mohammad Saadatnia

Volume 16, Issue 2 , April 2017, , Pages 72-77

  Background: The usefulness of the modified Atkins diet (mAD) in refractory epilepsy in adults has been rarely investigated. We aimed to evaluate the efficacy of mAD in adult with refractory epilepsy. Methods: In a controlled randomized clinical trial, we enrolled 66 refractory adult epileptic cases ...  Read More

Polymorphisms at activated protein C cleavage sites of factor V: Are they important in the absence of factor V Leiden?

Ehsan Kheradmand; Shaghayegh Haghjooy-Javanmard; Leila Dehghani

Volume 16, Issue 1 , January 2017, , Pages 30-33

  Background: Activated protein C (APC) inactivates factor V (FV) by cleavage of its heavy chain at Arg306, Arg506, Arg679, and Lys994. Mutational changes, which abolish APC cleavage sites, may predispose thrombosis by altering the inactivation process of FV. FV Leiden (FVL) (Arg506Glu) has been demonstrated ...  Read More

The effects of sodium valproate with fish oil supplementation or alone in migraine prevention: A randomized single-blind clinical trial.

Marzieh Tajmirriahi; Maryam Sohelipour; Keivan Basiri; Vahid Shaygannejad; Asgar Ghorbani; Mohammad Saadatnia

Volume 11, Issue 1 , March 2012, , Pages 21-24

  Background: Omega-3 polyunsaturated fatty acids (PUFA) have beneficial effects on both specific and non-specific inflammatory reactions. The aim of this study was to evaluate the effect of dietary supplementation with fish oil in migraine prevention.Methods: A 12-week, randomized, single-blind clinical ...  Read More